Datasheet | June 5, 2024

Optimized Medium For CAR-T Cell Therapy Development: NB-ROC™ T Cell SF Medium

NBROC

NB-ROC is a media specifically designed for the development of CAR-T cell therapy. It aims to enhance transduction while preserving essential characteristics, which results in a higher yield of CAR+ cells and improved patient outcomes. NB-ROC also decreases the quantity of viral vector required, reducing production costs and increasing the safety of the final therapeutic dose. The media aids cell proliferation and maintains quality indicators such as cell health and viability, leading to more effective and safer cancer treatments through T cell immunotherapy. Produced in a GMP environment, NB-ROC holds ISO 13485:2016 certification and comes with a Certificate of Compliance or Analysis upon delivery. Licensing options are available as well.

access the Datasheet!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online